Elastrin Therapeutics Inc.
Restoring the Elastic of Life
Elastin degradation is a leading contributor to heart disease, aneurysms and COPD. Learn more
Our team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries.
The platform significantly improves the efficacy of drugs and eliminates side-effects by combining particle design with elastin targeting.
Antibody for elastin targeting
Special configuration to keep out of cells
Drug release over ~10 days
Image: Naren Vyavahare
Meet the Team
Our interdisciplinary team has extensive track records in antibody development, bioengineering, molecular medicine, medical engineering, and environmental health as well as regulatory approvals, and finance & management. Our team members have a proven track record in entrepreneurship and successful startups.
Get in Touch
We’re happy to hear from you. Contact us today to learn more about our business, what we are up to and how you can support us.